NCT06911658

Brief Summary

Infectious complications represent the most common postoperative adverse events following esophagectomy for cancer, such as pneumonia (15% of cases). These complications increase immediate risks, lengthen hospital stays, and worsen patient quality of life. The population includes patients admitted to intensive care after esophagectomy for cancer between January 1, 2017, and December 31, 2024. The study focuses on this population due to the increasing incidence of esophageal cancer, the increased use of surgery for these indications, and the importance of postoperative infections in these complex procedures, despite their understudied nature in the current literature. Identifying modifiable risk factors could lead to corrective measures and thus improve the prognosis of postoperative patients. The research focuses primarily on the incidence, types, factors, and prognosis associated with the occurrence of infections after esophagectomy for cancer. It also includes an analysis of the pathogens involved, their resistance profiles, and the antibiotic therapies used in first-line probabilistic treatment.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
350

participants targeted

Target at P75+ for all trials

Timeline
3mo left

Started Aug 2025

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress76%
Aug 2025Jul 2026

First Submitted

Initial submission to the registry

March 13, 2025

Completed
22 days until next milestone

First Posted

Study publicly available on registry

April 4, 2025

Completed
5 months until next milestone

Study Start

First participant enrolled

August 27, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 28, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 28, 2026

Last Updated

December 17, 2025

Status Verified

December 1, 2025

Enrollment Period

11 months

First QC Date

March 13, 2025

Last Update Submit

December 9, 2025

Conditions

Keywords

Postoperative infectionEsophagectomy complications

Outcome Measures

Primary Outcomes (1)

  • Incidence of infections after esophagectomy for cancer

    until the day 28

Secondary Outcomes (5)

  • Number of postoperative infectious episodes per participant, classified by anatomical site, as assessed retrospectively from hospitalization records

    until the day 28

  • Presence of predefined pathogens during postoperative infectious episodes, as assessed retrospectively from hospitalization records

    until the day 28

  • Association between preoperative and perioperative clinical variables and the occurrence of postoperative infection, as assessed by multivariable logistic regression analysis of hospitalization records

    until the day 28

  • Occurrence of major complications (sepsis, septic shock, AKI, ARDS, or death) within 28 days after esophagectomy, as documented in hospitalization records, compared between infected and non-infected patients

    until day 28

  • Association between postoperative infection and length of hospital stay, as assessed by linear regression analysis of hospitalization records

    until day 28

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Hospitalized patients in intensive care unity.

You may qualify if:

  • Patients over 18 years of age
  • Underwent esophagectomy for cancer between January 1, 2017, and December 31, 2024
  • Scheduled admission to intensive care for postoperative monitoring

You may not qualify if:

  • Opposition to the use of data

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Hôpital Saint-Louis - APHP

Paris, 75010, France

RECRUITING

Saint Louis Hospital

Paris, 75010, France

NOT YET RECRUITING

MeSH Terms

Conditions

Postoperative ComplicationsInfectionsPneumonia

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsRespiratory Tract InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • François DEPRET, MD-PHD

    APHP

    PRINCIPAL INVESTIGATOR
  • DEPRET

    APHP

    PRINCIPAL INVESTIGATOR

Central Study Contacts

François DEPRET, MD-PHD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 13, 2025

First Posted

April 4, 2025

Study Start

August 27, 2025

Primary Completion (Estimated)

July 28, 2026

Study Completion (Estimated)

July 28, 2026

Last Updated

December 17, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations